These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28259761)

  • 1. Re: Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy: K. E. M. van Kessel, W. Beukers, I. Lurkin, A. Ziel-van der Made, K. A. van der Keur, J. L. Boormans, L. Dyrskjøt, M. Márquez, T. F. Ørntoft, F. X. Real, U. Segersten, N. Malats, P.-U. Malmström, W. Van Criekinge and E. C. Zwarthoff J Urol 2017;197:590-595.
    Wang Z; Bi SS; Wang L
    J Urol; 2017 Jun; 197(6):1573. PubMed ID: 28259761
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: A Urine Based Genomic Assay to Triage Patients with Hematuria for CystoscopyK. E. M. van Kessel, J. J. de Jong, A. C. J. Ziel-van der Made, H. Roshani, S. M. Haensel, J. H. Wolterbeek, E. R. Boevé, E. H. G. M. Oomens, N. J. van Casteren, M. Krispin, J. L. Boormans, E. W. Steyerberg, W. van Criekinge and E. C. Zwarthoff
    Yin G; Tang J; Wang L
    J Urol; 2020 Nov; 204(5):1062. PubMed ID: 32628098
    [No Abstract]   [Full Text] [Related]  

  • 3. Commentary on: "Comprehensive transcriptional analysis of early-stage urothelial carcinoma." Hedegaard J, Lamy P, Nordentoft I, Algaba F, Høyer S, Ulhøi BP, Vang S, Reinert T, Hermann GG, Mogensen K, Thomsen MB, Nielsen MM, Marquez M, Segersten U, Aine M, Höglund M, Birkenkamp-Demtröder K, Fristrup N, Borre M, Hartmann A, Stöhr R, Wach S, Keck B, Seitz AK, Nawroth R, Maurer T, Tulic C, Simic T, Junker K, Horstmann M, Harving N, Petersen AC, Calle ML, Steyerberg EW, Beukers W, van Kessel KE, Jensen JB, Pedersen JS, Malmström PU, Malats N, Real FX, Zwarthoff EC, Ørntoft TF, Dyrskjøt L. Cancer Cell. 2016 Jul 11;30(1):27-42.
    Lee BH
    Urol Oncol; 2017 Sep; 35(9):576-577. PubMed ID: 28789929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Erratum for the Report "Global distribution of earthworm diversity" by H. R. P. Phillips, C. A. Guerra, M. L. C. Bartz, M. J. I. Briones, G. Brown, T. W. Crowther, O. Ferlian, K. B. Gongalsky, J. van den Hoogen, J. Krebs, A. Orgiazzi, D. Routh, B. Schwarz, E. M. Bach, J. Bennett, U. Brose, T. Decaëns, B. König-Ries, M. Loreau, J. Mathieu, C. Mulder, W. H. van der Putten, K. S. Ramirez, M. C. Rillig, D. Russell, M. Rutgers, M. P. Thakur, F. T. de Vries, D. H. Wall, D. A. Wardle, M. Arai, F. O. Ayuke, G. H. Baker, R. Beauséjour, J. C. Bedano, K. Birkhofer, E. Blanchart, B. Blossey, T. Bolger, R. L. Bradley, M. A. Callaham, Y. Capowiez, M. E. Caulfield, A. Choi, F. V. Crotty, A. Dávalos, D. J. Diaz Cosin, A. Dominguez, A. E. Duhour, N. van Eekeren, C. Emmerling, L. B. Falco, R. Fernández, S. J. Fonte, C. Fragoso, A. L. C. Franco, M. Fugère, A. T. Fusilero, S. Gholami, M. J. Gundale, M. Gutiérrez López, D. K. Hackenberger, L. M. Hernández, T. Hishi, A. R. Holdsworth, M. Holmstrup, K. N. Hopfensperger, E. Huerta Lwanga, V. Huhta, T. T. Hurisso, B. V. Iannone III, M. Iordache, M. Joschko, N. Kaneko, R. Kanianska, A. M. Keith, C. A. Kelly, M. L. Kernecker, J. Klaminder, A. W. Koné, Y. Kooch, S. T. Kukkonen, H. Lalthanzara, D. R. Lammel, I. M. Lebedev, Y. Li, J. B. Jesus Lidon, N. K. Lincoln, S. R. Loss, R. Marichal, R. Matula, J. H. Moos, G. Moreno, A. Morón-Ríos, B. Muys, J. Neirynck, L. Norgrove, M. Novo, V. Nuutinen, V. Nuzzo, M. Rahman P, J. Pansu, S. Paudel, G. Pérès, L. Pérez-Camacho, R. Piñeiro, J.-F. Ponge, M. I. Rashid, S. Rebollo, J. Rodeiro-Iglesias, M. Á. Rodríguez, A. M. Roth, G. X. Rousseau, A. Rozen, E. Sayad, L. van Schaik, B. C. Scharenbroch, M. Schirrmann, O. Schmidt, B. Schröder, J. Seeber, M. P. Shashkov, J. Singh, S. M. Smith, M. Steinwandter, J. A. Talavera, D. Trigo, J. Tsukamoto, A. W. de Valença, S. J. Vanek, I. Virto, A. A. Wackett, M. W. Warren, N. H. Wehr, J. K. Whalen, M. B. Wironen, V. Wolters, I. V. Zenkova, W. Zhang, E. K. Cameron, N. Eisenhauer.
    Science; 2020 Jul; 369(6503):. PubMed ID: 32732396
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry: T. M. van der Sluis, H. N. Bui, E. J. Meuleman, A. C. Heijboer, J. F. Hartman, N. van Adrichem, E. Boevé, W. de Ronde, R. J. van Moorselaar and A. N. Vis. J Urol 2012; 187: 1601-1606.
    Oefelein MG
    J Urol; 2012 Nov; 188(5):2020; author reply 2020-1. PubMed ID: 22999544
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: lower testosterone levels with luteinizing hormone-releasing hormone agonist therapy than with surgical castration: new insights attained by mass spectrometry. T. M. van der Sluis, H. N. Bui, E. J. Meuleman, A. C. Heijboer, J. F. Hartman,N. van Adrichem, E. Boevé, W. de Ronde, R. J. van Moorselaar and A. N. Vis. J Urol 2012; 187: 1601–1607.
    Crawford ED; Eisner J; Persson BE
    J Urol; 2013 Mar; 189(3):1168-9. PubMed ID: 23022003
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. T. Wolters, M. J. Roobol, P. J. van Leeuwen, R. C. van den Bergh, R. F. Hoedemaeker, G. J. van Leenders, F. H. Schröder and T. H. van der Kwast. J Urol 2011;185: 121-125.
    Moore CM; Klotz L; Emberton M
    J Urol; 2011 Sep; 186(3):1158-9; author reply 1159. PubMed ID: 21784490
    [No Abstract]   [Full Text] [Related]  

  • 8. Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.
    van Kessel KE; Beukers W; Lurkin I; Ziel-van der Made A; van der Keur KA; Boormans JL; Dyrskjøt L; Márquez M; Ørntoft TF; Real FX; Segersten U; Malats N; Malmström PU; Van Criekinge W; Zwarthoff EC
    J Urol; 2017 Mar; 197(3 Pt 1):590-595. PubMed ID: 27746284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Re: Urinary DNA Methylation Biomarkers for Noninvasive Prediction of Aggressive Disease in Patients with Prostate Cancer on Active Surveillance: F. Zhao, E. Olkhov-Mitsel, T. van der Kwast, J. Sykes, D. Zdravic, V. Venkateswaran, A. R. Zlotta, A. Loblaw, N. E. Fleshner, L. Klotz, D. Vesprini and B. Bapat J Urol 2017;197:335-341.
    Zhao F; Jeyapala R; Olkhov-Mitsel E; Vesprini D; Fleshner NE; Bapat B
    J Urol; 2018 May; 199(5):1354-1355. PubMed ID: 29428633
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Delila Gasi Tandefelt, Joost L. Boormans, Hetty A. van der Korput, Guido W. Jenster, Jan Trapman. A 36-gene signature predicts clinical progression in a subgroup of ERG-positive prostate cancers. Eur Urol 2013;64:941-50.
    Sampson N; Berger P; Klocker H
    Eur Urol; 2014 Jun; 65(6):e102-3. PubMed ID: 24565966
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. P. E. van Kerrebroeck, A. C. van Voskuilen, J. P. Heesakkers, A. A. Lycklama a Nijholt, S. Siegel, U. Jonas, C. J. Fowler, M. Fall, J. B. Gajewski, M. M. Hassouna, F. Cappellano, M. M. Elhilali, D. F. Milam, A. K. Das, H. E. Dijkema and U. van den Hombergh. J Urol 2007; 178: 2029-2034.
    Reynolds WS; Bales GT
    J Urol; 2008 Jun; 179(6):2483-4; author reply 2484. PubMed ID: 18436258
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer: S. Loeb, M. G. Sanda, D. L. Broyles, S. S. Shin, C. H. Bangma, J. T. Wei, A. W. Partin, G. G. Klee, K. M. Slawin, L. S. Marks, R. H. N. van Schaik, D. W. Chan, L. J. Sokoll, A. B. Cruz, I. A. Mizrahi and W. J. Catalona J Urol 2015;193:1163-1169.
    Shah N; Ioffe V
    J Urol; 2015 Dec; 194(6):1825-6. PubMed ID: 26354886
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: air cystoscopy is superior to water cystoscopy for the diagnosis of active hematuria. A. Ciudin, M. G. Diaconu, D. Gosalbez, L. Peri, E. Garcia-Cruz, A. Franco and A. Alcaraz J Urol 2013;190:2097-2101.
    Kumar S; Choudhari GR; Devana SK
    J Urol; 2014 Jun; 191(6):1931-2. PubMed ID: 24513139
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: air cystoscopy is superior to water cystoscopy for the diagnosis of active hematuria: A. Ciudin, M. G. Diaconu, D. Gosalbez, L. Peri, E. Garcia-Cruz, A. Franco and A. Alcaraz J Urol 2013;190:2097-2101.
    Gupta S; Singh V; Sharma K
    J Urol; 2014 Jun; 191(6):1931. PubMed ID: 24513146
    [No Abstract]   [Full Text] [Related]  

  • 15. A Prospective Blinded Evaluation of Urine-DNA Testing for Detection of Urothelial Bladder Carcinoma in Patients with Gross Hematuria.
    Dahmcke CM; Steven KE; Larsen LK; Poulsen AL; Abdul-Al A; Dahl C; Guldberg P
    Eur Urol; 2016 Dec; 70(6):916-919. PubMed ID: 27417036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Maud Rijnders, Ronald de Wit, Joost L. Boormans, Martijn P.J. Lolkema, Astrid A.M. van der Veldt. Systematic Review of Immune Checkpoint Inhibition in Urological Cancers. Eur Urol. 2017;72:411-23: Beyond the Survival Rate, Health-related Quality of Life is Important.
    Martinez Merizalde Balarezo N; Monroe Rivera M; Tejada RA
    Eur Urol; 2018 Mar; 73(3):e66. PubMed ID: 29097096
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: Factors predicting prostatic biopsy Gleason sum under grading: D. A. Stackhouse, L. Sun, F. R. Schroeck, J. Jayachandran, A. A. Caire, C. O. Acholo, C. N. Robertson, D. M. Albala, T. J. Polascik, C. F. Donatucci, K. E. Maloney and J. W. Moul J Urol 2009; 182: 118-124.
    Labanaris AP; Kühn R; Zugor V
    J Urol; 2010 Jan; 183(1):396-7; author reply 397-8. PubMed ID: 19945124
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Pre-eclampsia: an important risk factor for asymptomatic heart failure. C. Ghossein-Doha, J. van Neer, B. Wissink, N. Breetveld, L. J. de Windt, A. P. J. van Dijk, M. J. van der Vlugt, M. C. H. Janssen, W. M. Heidema, R. R. Scholten and M. E. A. Spaanderman. Ultrasound Obstet Gynecol 2017; 49: 143-149.
    Boardman H
    Ultrasound Obstet Gynecol; 2017 Jan; 49(1):23-24. PubMed ID: 28058791
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. C. G. Roehrborn, S. N. Gange, N. D. Shore, J. L. Giddens, D. M. Bolton, B. E. Cowan, B. T. Brown, K. T. McVary, A. E. Te, S. S. Gholami, P. Rashid, W. G. Moseley, P. T. Chin, W. T. Dowling, S. J. Freedman, P. F. Incze, K. S. Coffield, F. D. Borges and D. B. Rukstalis J Urol 2013;190:2161-2167.
    Gupta S; Singh V; Goel A
    J Urol; 2014 Jun; 191(6):1934-5. PubMed ID: 25405255
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: the prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study. C. G. Roehrborn, S. N. Gange, N. D. Shore, J. L. Giddens, D. M. Bolton, B. E. Cowan, B. T. Brown, K. T. McVary, A. E. Te, S. S. Gholami, P. Rashid, W. G. Moseley, P. T. Chin, W. T. Dowling, S. J. Freedman, P. F. Incze, K. S. Coffield, F. D. Borges and D. B. Rukstalis J Urol 2013;190:2161-2167.
    Mavuduru RS; Devana SK; Nayak B
    J Urol; 2014 Jun; 191(6):1934. PubMed ID: 24631348
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.